Science researchers at Georgetown University recently published a study in the Journal of Infectious Diseases that shows that the human papillomavirus (HPV) vaccine a Georgetown University doctor helped to invent has lead to the number of infections among teenage girls across the United States being cut in half. According to a Georgetown University news article, the vaccine was created to treat and get rid of two forms of the HPV virus, which results in most cervical cancer cases nationwide, along with head and neck cancer, anal cancer and penile cancer.
“This is just fantastic news – better than expected,” said Dr. Richard Schlegel, chair of department of pathology and a professor of oncology at Georgetown Lombardi Comprehensive Cancer Center. “A reduction of half of HPV infections in girls shows that the vaccine is working well in the general population — just as we saw in the clinical trials. This is very good news.”
Georgetown University contributes a great deal of research in the life sciences, such as vaccine research, every year. Lab suppliers interested in marketing life science solutions and increasing lab sales leads may also be interested to know that Georgetown University is a very well-funded market. According to recent NIH and NSF funding statistics, Georgetown University received $59.5 million in 2012. Georgetown University was awarded $53.5 million by the NIH in 2012. The research funding was distributed among various life science departments such as biochemistry, biology, family medicine, internal medicine, microbiology, neurosciences and pharmacology. For a full list of departments at Georgetown University receiving NIH awards organized by department name, number of awards received and total funding awarded, please visit the NIH website.
Dr. Schlegel works with a student in his lab
Image courtesy of Georgetown University
In addition to receiving $53.5 million from the NIH, Georgetown University also received $6 million from the NSF in 2012. The NSF-funded projects took place in various life science disciplines including behavioral systems, population and community ecology, cross-EF activities and evolutionary processes. The NIH life science project receiving the most funding was called “Theoretical Studies of Cytosol” and received $184,500. For a full list of projects receiving NSF funding at Georgetown University, please visit the NSF website.
If you are a lab supplier interested in marketing your life science solutions and increasing lab sales leads at life science marketing events in the D.C. area, Biotechnology Calendar, Inc. invites you to attend our annual Georgetown BioResearch Product Faire™ Event held on October 17, 2013. Last year, the Georgetown BioResearch Product Faire™ Event attracted 223 attendees, of which 59 were purchasing agents, professors and post docs, and 24 were lab managers. The attendees came from 13 different research buildings and 21 departments across campus.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that has been organizing life science marketing events at top research universities across the country for 20 years. For more information on our Georgetown BioResearch Product Faire™ Event, or to view more funding statistics for Georgetown University, click on the button below. If you’d like to market your life science solutions and increase lab sales leads at life science marketing events closer to home, we encourage you to view our 2013 calendar of events.
